Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.24−0.01 (-5.06%)
Close on Nov 19, 2026Market cap $5.22MP/E –Yield –
Soligenix net income
Net income is the profit left for shareholders after every expense, interest and tax.
Soligenix's net income for the twelve months ending Jun 30, 2026 was -$10.24M. For fiscal 2025 it was -$11.08M. The highest annual figure on record is -$2.38M in fiscal 2011.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.08M | – |
| FY2024 | Dec 31, 2024 | -$8.27M | – |
| FY2023 | Dec 31, 2023 | -$6.14M | – |
| FY2022 | Dec 31, 2022 | -$13.80M | – |
| FY2021 | Dec 31, 2021 | -$12.55M | – |
| FY2020 | Dec 31, 2020 | -$17.69M | – |
| FY2019 | Dec 31, 2019 | -$9.36M | – |
| FY2018 | Dec 31, 2018 | -$8.90M | – |
| FY2017 | Dec 31, 2017 | -$7.15M | – |
| FY2016 | Dec 31, 2016 | -$3.25M | – |
| FY2015 | Dec 31, 2015 | -$7.83M | – |
| FY2014 | Dec 31, 2014 | -$6.71M | – |
| FY2013 | Dec 31, 2013 | -$10.06M | – |
| FY2012 | Dec 31, 2012 | -$4.16M | – |
| FY2011 | Dec 31, 2011 | -$2.38M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.90M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.99M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.64M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.92M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.82M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.61M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.39M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.59M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.36M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.78M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.58M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.64M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.10M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.86M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.56M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.38M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$963.09K | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.31M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.73M | – |
| Q4 FY2016 | Dec 31, 2016 | -$329.96K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.67M | – |
| Q2 FY2016 | Jun 30, 2016 | -$92.78K | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.15M | – |
See a number that looks wrong?